Home › Non-Small Cell Lung Cancer › Mississippi › Jackson
Non-Small Cell Lung Cancer clinical trials in Jackson, MS
5 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Jackson (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- University of Mississippi Medical Center, Jackson
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecruitingPhase 3
- University of Mississippi Medical Center, Jackson
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RecruitingPhase 3
- Jackson Oncology Associates, PLLC, Jackson
- Jackson Oncology Associates, PLLC, Jackson
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RecruitingPhase 2/3
- Jackson Oncology Associates - The Hederman Cancer Center, Jackson
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecruitingPhase 2
- University of Mississippi Medical Center, Jackson
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY120 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH56 studies
- Washington, DC55 studies
Other studies in Jackson
- Obesity8 studies
- Overweight6 studies
- Steatotic Liver Disease5 studies
- Lung Cancer5 studies
- Prostate Cancer5 studies
- Breast Cancer5 studies
- Sickle Cell Disease5 studies
- Heart Failure5 studies
- Type 2 Diabetes5 studies
- Burkitt Lymphoma4 studies
- Acute Myeloid Leukemia4 studies
- Attention Deficit Hyperactivity Disorder4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.